Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trialJean‐Michel Graciès, Philippe Picaut, Allison Brashear et al.|The Lancet Neurology|2015Cited by 213
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: LaurietCecília Monteiro, William Alvin McElveen, Sandra Sanabria Bohórquez et al.|Neurology|2023Cited by 104
Efficacy and safety of abobotulinumtoxinA in spastic lower limbJean‐Michel Graciès, A A Skoromets, Alberto Esquenazi et al.|Neurology|2017Cited by 96